Kolon TissueGene, Inc.

Languages

  • English
  • Korean
  • English
  • About
    • Overview
    • History
    • Management Team
    • Board of Directors
    • Advisory Boards
  • Technology
    • Overview
    • TG-C
    • Publications
  • Product Pipeline
    • Overview
    • Applications
  • Clinical Trials
  • IR
    • Stock Data
    • PR
    • IR Material
    • Disclosure
    • Analyst Report
  • Partnering/Alliances
  • Contact

IR Material

IR

IR

  • Stock Data
  • PR
  • IR Material
  • Disclosure
  • Analyst Report
IR Letter

IR Letter

Jun 1, 2023
[TG-C 관련 논문] Therapeutic Advances in Musculoskeletal Disease

[TG-C 관련 논문] Therapeutic Advances in Musculoskeletal Disease

Mar 29, 2023
사업보고서 공고

사업보고서 공고

Mar 20, 2023
주주총회 소집공고

주주총회 소집공고

Mar 13, 2023
사업보고서 공고

사업보고서 공고

Mar 21, 2022
제23기 주주총회 소집공고

제23기 주주총회 소집공고

Mar 14, 2022
사업보고서 공고

사업보고서 공고

Mar 23, 2021
주주총회 소집공고

주주총회 소집공고

Mar 15, 2021
공지사항

공지사항

Mar 26, 2020
홈페이지 공지 사항

홈페이지 공지 사항

Aug 26, 2019
  • 1
  • 2
  • 3
  • Next »
© 2023 Kolon TissueGene, Inc. All Rights Reserved.

This information—including product information—is intended only for residents of the United States. The products discussed on this site may have different labeling in different countries.

Privacy Policy Disclaimer Sitemap Ethical Management